Clinical trial
Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally
NCT00436046 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00436046 |
|---|---|
| Title | Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally |
| Official title | Type 1 Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Trivalent inactivated influenza virus vaccine (2006-2007 formulation), Type 1 interferon |
| Enrollment | 95 |
| Start date | Mar 1, 2007 |
| Primary completion | Apr 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Feb 16, 2007 |
| Last update posted | Jun 13, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: